Orchid Research Grants 2017

Every year over 50,000 men in the UK will be diagnosed with a male specific cancer – testicular, prostate and penile. Founded in 1996, Orchid is the UK’s leading cancer charity dedicated to male specific cancers. Orchid works to improve the lives of people affected by or with a personal interest in these cancers through a range of support services, education and awareness campaigns underpinned by a world class research programme. Looking forward, there is still much work to be done. The charity is committed to working in an area where there are very real unmet needs and not enough research funding. Building on our current success, informed by the knowledge and expertise of a range of stakeholders and taking into consideration opportunities and the external environment, Orchid’s long term research strategy is to offer the best possible care and support for men and their families. Orchid funds research to improve our understanding of male specific cancers: testicular, prostate and penile. This includes identifying new ways to detect and stage disease, new treatments and novel strategies to improve survival.

Orchid is now inviting full applications for research grants. These will be available to researchers based in the UK and Ireland to fund research into male specific cancers. These grants are available either to medically qualified applicants, post-doctoral scientists or allied health professionals for clinical, laboratory and/or epidemiological research into male specific cancers.

Applications may be for any sum of money and may include the costs of personnel, equipment and consumables where appropriate. We particularly welcome applications from those working in the field of penile cancer.

Grants are for a specified period of up to three years for research carried out in the United Kingdom and Ireland and may include programme funding, project grants or prize studentships. The closing date for applications is Thursday 14 September 2017 at 5pm.

To download the application form please click here.

Was this page useful?

  • Please type the code above, so you can submit the form.
  • This field is for validation purposes and should be left unchanged.